07262017Headline:

Kansas City, Missouri

HomeMissouriKansas City

Email Brett Emison Brett Emison on LinkedIn Brett Emison on Twitter Brett Emison on Facebook Brett Emison on Avvo
Brett Emison
Brett Emison
Attorney • (800) 397-4910

US Prosecutors Seek $1 Billion From Johnson & Johnson Over Risperdal

Comments Off

I wrote earlier this week about Johnson & Johnson’s recall problems. In another blow to J&J’s image, US prosecutors are seeking $1 billion from Johnson & Johnson for off label (unapproved) marketing of its anti-psychotic drug, Risperdal. According to reports, prosecutors are pushing J&J to reach a settlement soon.

Atypical anti-psychotic drugs, like Risperdal, were designed to treat ailments like schizophrenia or bipolar disorder, but have been marketed and used extensively for "off label" or unapproved purposes. These drugs have serious side effects including tardive sykinesia, hyperglycemia, diabetes, pancreatitis, and heart attack.

Check with your physician if you have been prescribed Risperdal or other atypical anti-psychotic drugs.

More Information:

(c) Copyright Brett A. Emison